| Literature DB >> 23717566 |
Liming Weng1, Andrew Piotrowski, Donald A Morrison.
Abstract
Development of natural competence in S. pneumoniae entails coordinated expression of two sets of genes. Early gene expression depends on ComE, a response regulator activated by the pheromone CSP (Competence-Stimulating-Peptide). Subsequently, an early gene product (the alternative sigma factor ComX) activates expression of late genes, establishing the competent state. Expression of both sets of genes is transient, rapidly shut off by a mechanism that depends on the late gene, dprA. It has been thought that the rapid shutoff of late gene expression is the combined result of auto-inhibition of ComE and the instability of ComX. However, this explanation seems incomplete, because of evidence for ComX-dependent repressor(s) that might also be important for shutting off the response to CSP and identifying dprA as such a gene. We screened individual late gene mutants to investigate further the roles of ComX-dependent genes in competence termination. A ΔdprA mutant displayed a prolonged late gene expression pattern, whereas mutants lacking cbpD, cibABC, cglEFG, coiA, ssbB, celAB, cclA, cglABCD, cflAB, or radA, exhibited a wild-type temporal expression pattern. Thus, no other gene than dprA was found to be involved in shutoff. DprA limits the amounts of ComX and another early gene product, ComW, by restriction of early gene expression rather than by promoting proteolysis. To ask if DprA also affects late gene expression, we decoupled late gene expression from early gene regulation. Because DprA did not limit ComX activity under these conditions, we also conclude that ComX activity is limited by another mechanism not involving DprA.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23717566 PMCID: PMC3661451 DOI: 10.1371/journal.pone.0064197
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Organization of late genes of the S. pneumoniae competence regulon.
Internal deletion mutants studied in this paper are indicated by blue ovals. C represents the cinbox promoter, TACGAATA. Fill colors symbolize the functions of proteins, as indicated by the key on the right. Bent arrow and lollipop stand for constitutive promoter and terminator respectively. Red borders indicate genes required for transformation; green borders indicate genes not required for transformation. Black borders indicate genes whose importance for transformation has not been directly determined. Genes described by numbers (ORF numbers in TIGR4) are those whose functions in competence are unknown. The ORF numbers for named late genes are: cinA(sp1941), cbpD(sp2201), cibA(sp0125), coiA(sp0978), dprA(sp1266), ssbB(sp1908), cclA(sp1808), cglA(sp2053), celA(sp0054), cflA(sp2208). The late gene clusters and associated cinbox are as in Peterson et al [9], but without cases of apparent read-through transcription identified in [34].
Bacterial strains used in this study.
| Strain | Description | Source (a) or reference |
| Streptococcus. pneumoniae | ||
| CPM7 | CP1250, but ssbB−::lacZ::ssbB+; SsbB+ SmR CmR |
|
| CP1250 | Rx, but cps3D hex cps3D malM511 str-1 bgl-1; Hex− Mal− SmR Bga− |
|
| CP1275 | CP1250, but ΔcbpD::PcKan; KanR |
|
| CP1279 | CP1250, but ΔcibABC::PcKan; KanR |
|
| CP1333 | CP1250, but ΔcglEFG::PcKan; KanR |
|
| CP1344 | CP1250, but ΔclpC::PCTet; TetR |
|
| CP1359 | CP1250, but ΔclpP::PcTet; TetR |
|
| CP1389 | CP1250, but ΔdprA::PcKan; KanR |
|
| CP1415 | CP1250, but Δ |
|
| CP1500 | Rx, hex nov-r1, byr-r, ery-r1,ery-r2, str-1;NovR EmR SmR, |
|
| CP1793 | CP1250, but ΔcoiA::PcKan; KanR |
|
| CP1851 | CP1250, but ΔclpE::PcErm; EmR |
|
| CP1862 | CP1250, but ΔcelAB::PcKan; KanR | This work |
| CP1863 | CP1250, but ΔcclA::PcKan; KanR | This work |
| CP1868 | CP1250, but ΔcglABCD::PcKan; KanR | This work |
| CP1869 | CP1250, but ΔcflAB::PcKan; KanR | This work |
| CP1890 | CP1250, but ssbB−::lacZ::ssbB+, ΔclpP::PcTet; CmR TetR | CPM7×CP1359 |
| CP1894 | CP1250, but ssbB−::lacZ::ssbB+, ΔdprA::PcKan; CmR KanR | CPM7×CP1389 |
| CP1895 | CP1250, but ssbB−::lacZ::ssbB+, ΔclpP, ΔdprA; CmR KanR TetR | CP1890×CP1389 |
| CP1896 | CP1250, but aga::comX::comW::PcKan; KanR | This work |
| CP1961 | CP2000, but aga::comX::comW, ssbB−::lacZ::ssbB+; CmR KanR | CP1896×CP2000×CPM7 |
| CP1962 | CP1961, but ΔclpE::PcErm; EmR | CP1961×CP1851 |
| CP1963 | CP1961, but ΔclpC::PCTet; TetR | CP1961×CP1344 |
| CP1902 | CP1961, but ΔclpC::PCTet, ΔclpE::PcErm; TetR EmR | CP1962×CP1344 |
| CP1932 | CP1902, but ΔdprA::PcKan; KanR | CP1902×CP1389 |
| CP2000 | CP1250, but Δcps; Hex− Mal− Cps− SmR Bga− | This work |
| CP2108 | CP2000, but ssbB−::lacZ::ssbB+, ΔcomA::PcErm; SmR CmR EmR | CP2000×CPM7×CP1415 |
| CP2109 | CP2108, but ΔcbpD::PcKan; KanR | CP2108×CP1275 |
| CP2110 | CP2108, but ΔcibABC::PcKan; KanR | CP2108×CP1279 |
| CP2111 | CP2108, but ΔcoiA::PcKan; KanR | CP2108×CP1793 |
| CP2112 | CP2108, but ΔcglEFG::PcKan; KanR | CP2108×CP1333 |
| CP2113 | CP2108, but ΔdprA::PcKan; KanR | CP2108×CP1389 |
| CP2114 | CP2108, but ΔcclA::PcKan; KanR | CP2108×CP1863 |
| CP2115 | CP2108, but ΔcflAB::PcKan; KanR | CP2108×CP1869 |
| CP2116 | CP2108, but ΔcelAB::PcKan; KanR | CP2108×CP1862 |
| CP2117 | CP2108, but ΔcglABCD::PcKan; KanR | CP2108×CP1868 |
| CP2118 | CP1250, but ΔradA::PcSpc; SpcR | This work |
| CP2119 | CP2108, but ΔradA::PcSpc; SpcR | CP2108×CP2118 |
| CP2125 | CP2108, but ΔclpP::PcTet; TetR | CP2108×CP1359 |
| CP2126 | CP2125, but ΔcbpD::PcKan; KanR | CP2125×CP1275 |
| CP2127 | CP2125, but ΔcibABC::PcKan; KanR | CP2125×CP1279 |
| CP2128 | CP2125, but ΔcglEFG ::PcKan; KanR | CP2125×CP1333 |
| CP2129 | CP2125, but ΔdprA::PcKan; KanR | CP2125×CP1389 |
| CP2130 | CP2125, but ΔcoiA::PcKan; KanR | CP2125×CP1793 |
| CP2131 | CP2125, but ΔcelAB::PcKan; KanR | CP2125×CP1862 |
| CP2132 | CP2125, but ΔcclA::PcKan; KanR | CP2125×CP1863 |
| CP2133 | CP2125, but ΔcglABCD::PcKan; KanR | CP2125×CP1868 |
| CP2134 | CP2125, but ΔcflAB::PcKan; KanR | CP2125×CP1869 |
| CP2135 | CP2125, but ΔradA::PcSpc; SpcR | CP2125×CP2119 |
| CP2139 | CP2108, but ΔssbB::PcKan; KanR | This work |
| CP2140 | CP2125, but ΔssbB::PcKan; KanR | This work |
| CP2143 | CP2108, but ΔPc-cinA::PcKan; KanR | This work |
| CP2144 | CP2125, but ΔPc-cinA::PcKan; KanR | This work |
| Escherichia coli | ||
| DH5α | F-recA1, endA1 hsdR17 phoA supE44 thi-1 gyrA96 | Invitrogen |
| Saccharomyces cerevisiae | ||
| NSY468 | MATa, trp1-901, leu2-3, l 12, ura3-52, his3-200, gal4Δ, gal80ΔGAL2-ADE2, LYS2::GAL1-HIS3, met2::GAL7-lacZ |
|
| NSY752 | MATα, trp1-901, leu2-3, l 12, ura3-52, his3-200, gal4Δ, gal80ΔGAL2-ADE2, LYS2::GAL1-HIS3, met2::GAL7-lacZ |
|
Crosses are indicated as recipient X donor genomic DNA.
Primers used for strain construction.
| Primer | Sequence (5′-3′) | Size (kb) | Construct | |
|
| ||||
| DAM303 |
| 0.8 | KanR marker | |
| DAM304 |
| |||
| Δ | ||||
| TTM01 |
| 0.8 | Upstreamfragment | |
| TTM02 |
| |||
| DAM823 |
| 1.5 | Downstreamfragment | |
| DAM827 |
| |||
| Δ | ||||
| DAM934 |
| 0.7 | Upstreamfragment | |
| DAM935 |
| |||
| BVD 104 |
| 1.0 | Downstreamfragment | |
| BVD 105 |
| |||
| Δ | ||||
| BVD26 |
| 0.8 | Upstreamfragment | |
| BVD27 |
| |||
| BVD28 |
| 1.5 | Downstreamfragment | |
| BVD29 |
| |||
| Δ | ||||
| DAM305 |
| 0.7 | Upstreamfragment | |
| DAM306 |
| |||
| DAM307 |
| 0.9 | Downstreamfragment | |
| DAM308 |
| |||
| Δ | ||||
| DAM313 |
| 1.6 | Upstreamfragment | |
| DAM314 |
| |||
| DAM315 |
| 0.8 | Downstreamfragment | |
| DAM316 |
| |||
| Δ | ||||
| DAM419 |
| 1.2 | Upstream fragment | |
| DAM420 |
| |||
| DAM421 |
| 1.5 | Downstream fragment | |
| DAM422 |
| |||
| Δ | ||||
| DAM563 |
| 1.0 | Upstream fragment | |
| DAM564 | ATGGGCCC-TGCCATCATTTGATTCAAGAAG | |||
| DAM565 | GGATCC-ATAACGGCTGGATTACGGCAACCT | 2.0 | Downstream fragment | |
| DAM566 |
| |||
| Δ | ||||
| DAM659 |
| 1.1 | Upstream fragment | |
| DAM660 | CGCGGATCC-TTTCAACTGCTTATTTATTTGC | |||
| DAM661 | ACGTGGGCCC-GGAAGGATAAATGTTGTAGATTAG | 0.8 | Downstream fragment | |
| DAM662 |
| |||
| Δ | ||||
| DAM663 |
| 1.1 | Upstream fragment | |
| DAM664 | CGCGGATCC-TAGTATAATGGAGAAACATAGATAAG | |||
| DAM665 | ACGTGGGCCC-TTGTTTGATAAAGTCCAATTTC | 1.2 | Downstream fragment | |
| DAM666 |
| |||
| Δ | ||||
| DAM680 |
| 1.2 | Upstreamfragment | |
| DAM679 | CGCGGATCC-TCCTCACCTATACTATTCGCAAAG | |||
| DAM682 | ACGTGGGCCC-TGATTTTACTGGAAGCAGTAGTC | 1.0 | Downstreamfragment | |
| DAM681 |
| |||
| Δ | ||||
| DAM684 |
| 1.2 | Upstreamfragment | |
| DAM683 | CGCGGATCC-AATCATGGAATTTAGGACAATTAAAG | |||
| DAM686 | ACGTGGGCCC-TCATAAAAACAAAAATGTTTAG | 1.0 | Downstreamfragment | |
| DAM685 |
| |||
| Δ | ||||
| DAM936 |
| 1.0 | Upstreamfragment | |
| DAM937 |
| |||
| DAM938 |
| 1.2 | Downstreamfragment | |
| DAM939 |
| |||
|
| ||||
| DAM786 |
| 1.4 | aga::comX | |
| PL82 |
| |||
| DAM791 |
| 0.4 | PcKan:rafE | |
| DAM793 |
| |||
| DAM794 |
| 2.0 | comW | |
| DAM790 |
| |||
|
| ||||
| DAM967 | gta | 0.9 | pGBDUC2::dprA | |
| DAM968 | gcat | |||
| DAM969 | cagt | 1.3 | pACT2::comD | |
| DAM970 | gcat | |||
| DAM971 | gtac | 0.8 | pACT2::comE | |
| DAM972 | gcat | |||
| DAM973 | gtac | 0.5 | pACT2::comX | |
| DAM974 | gcat | |||
| DAM975 | gtca | 0.3 | pACT2::comW | |
| DAM976 | gcat | |||
| DAM989 | gact | 1.2 | pACT2::recA | |
| DAM990 | gtca | |||
Plasmids used in this studies.
| Plasmid | Description | Source |
| pACT2 | shuttle vector for yeast 2-hybrid, carrying Gal4 activating domain (AD) | Clontech Labs, Inc. |
| pGBDUC2 | shuttle vector for yeast 2-hybrid, carrying Gal4 DNA binding domain (BD) |
|
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pACT2- | pACT2 derivative, carrying AD- | This work |
| pGBDUC2- | pGBDUC2 derivative, carrying BD- | This work |
Comparison of transformation efficiency of new strains with literature.
| New allelecombination | Relative transformation rate | |||
| Strain(s) | Mutation | Literature | Experimental | |
| ClpP+ | ClpP− | |||
|
|
| 1 | ||
|
|
| 1 | ||
|
|
| 1 | ||
|
|
| 1 | 1 | 1 |
|
|
| 1 | 1 | 1 |
|
|
| 1 | 1 | .4 |
|
|
| .01 | .001 | .001 |
|
|
| 0 | .001 | .001 |
|
|
| 0 | .0001 | .001 |
|
|
| 0 | .001 | .001 |
|
|
| 0 | .001 | .0001 |
|
|
| 0 | .0001 | .0001 |
|
|
| 0 | .0001 | .0001 |
|
|
| 0 | .001 | .001 |
|
|
| .3 | .3 | 0.5 |
| CP2143, CP2144 | Äcinbox-Ä | 1 | 1 | 1 |
Relative transformation rates were calculated by comparing the transformation efficiencies of the mutants to that of CP2000.
The literature sources for the relative transformation rates of the mutants are found in Table 1 and/or in Table S2 in [7].
Figure 2Survey of effect of late gene mutations on exit from the competent state.
A. Late gene expression patterns were monitored in wild type and late gene mutants after CSP induction using a lacZ reporter inserted at the late gene ssbB. β-galactosidase activity (Miller units) was measured in culture samples harvested at indicated times after CSP induction. Each strain is indicated by its mutated competence gene (see Table 1). B. Growth patterns monitored as culture optical density at 550 nm before and after CSP treatment. Bracket indicates period of LacZ assay shown in panel A.
Figure 3Survey of effect of late gene mutations on exit from the competent state in the protease deficient ΔclpP background.
A. After CSP induction, late gene expression patterns were monitored in wild type and late gene mutants in ΔclpP background. The lacZ reporter and the measurement of β-galactosidase activity were done as described for Figure 2. Each strain is indicated by its mutant competence gene as listed in Table 1. B. Growth patterns monitored as culture optical density at 550 nm before and after CSP treatment. Bracket indicates period of LacZ assay shown in panel A.
Figure 4Prolonged appearance of ComX and ComW in a dprA mutant.
A. Late gene expresion in strains CPM7 (x, dprA +) and CP1894 (□, ΔdprA) was monitored by measuring β-galactosidase activity (Miller units) (−) in a culture treated with CSP, using a lacZ transcriptional fusion to the ssbB promoter. Points are averages of three samples and error bars represent their standard deviation. –, growth of parallel non-CSP treated cultures. B. Western analysis of samples taken in parallel to samples for late gene expression run in a separate gel, transferred to a separate membrane for each strain and probed with antisera specific to both ComX and ComW using the ECL substrate and imaged on a separate film for each strain. Each lane represents a cell lysate from 0.6 ml of culture.
Figure 5Prolonged accumulation of ComX and ComW in aΔclpPdprA − mutant but not in a ΔclpP mutant.
A. Late gene expression in strains CP1890 (x, dprA+ ΔclpP) and CP1895 (□, ΔdprA ΔclpP) was monitored by measuring β-galactosidase activity (Miller units) (–) in a culture treated with CSP. The lacZ reporter was in a transcriptional fusion to the ssbB promoter. Points are averages of three samples and error bars represent their standard deviation. –, growth of the cultures. B. Western blot analysis of samples taken in parallel to samples for late gene expression run in a separate gel, transferred to a separate membrane for each strain and probed with antisera specific to both ComX and ComW using the ECL substrate and imaged on a separate film for each strain. Each lane represents a cell lysate from 0.6 ml of culture.
Figure 6Screening of candidate DprA targets with yeast two-hybrid assay.
Images were taken at indicated time during the incubation of the diploids (BD-A+AD-D, BD-A+AD-E, BD-A+AD-X, BD-A+AD-W, BD-A+AD-R, BD-A+AD-<$>\raster(70%)="rg1"<$>) in four kinds of agar plates for five days: SD-Ura-Leu (A), SD-Ura-Leu-His (B), SD-Ura-Leu-His+1 mM 3AT (C) and SD-Ura-Leu-His+3 mM 3AT (D). AD, activating domain of pACT2; BD, DNA binding domain of pGBDCU2; A, dprA; D, comD; E, comE; X, comX; W, comW; R, recA; SD, synthetic defined medium; Ura, uracil; Leu, leucine; His, histidine; 3AT, 3-Amino-1,2,4-triazole.
Figure 7Lack of effect of DprA on late gene expression in an ectopic comXcomW strain.
A. Western blot analysis of samples taken at different times after induction with raffinose. Wild type, CP1896 (aga::comX::comW); ΔclpE, CP1962 (CP1896, but ΔclpE); ΔclpC, CP1963 (CP1896, but ΔclpC); ΔclpE ΔclpC, CP1964 (CP1896, but ΔclpE ΔclpC). B. Kinetics of competence induction and late gene expression induced with either CSP (Δ) or raffinose (□). During treatment of CP1902 (aga::comX::comW, ssbB::lacZ, ΔclpC,ΔclpE,) with either CSP (250 ng/ml) or raffinose (0.1%) at 30°C, samples were taken in parallel, to monitor transformation (–) and α-gal activity (–). β-gal activity is expressed in Miller Units with respect to the OD of the culture at each time point. C. Late gene expression of CP1902 treated with either CSP (Δ) or raffinose (□) or CP1932 (CP1902, ΔdprA) with either CSP (•) or raffinose (x) at as 30°C for B.
Figure 8Reduced levels of ComX and ComW under ectopic regulation of competence.
Late gene expression was induced in strain CP1932 (aga::comX::comW, ssbB::lacZ, ΔclpC, ΔclpE ) by 250 ng/ml CSP or 0.1% raffinose respectively at OD 0.1. The cultures were sampled at 0, 10, 20, 30, 40, 60, and 80 min after induction for western blotting assay. Two SDS-PAGE gels were run in parallel and probed with different antibodies: Top, PVDF membrane probed with anti-ComX antibody; Bottom, PVDF membrane probed with anti-ComW antibody.